DAA2254 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
91.8% Increase Gene Expression Level |
hippocampus |
Human |
|
DAA2261 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
40.3% Increase Gene Expression Level |
parietal lobe |
Human |
|
DAA2259 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
42.0% Increase Gene Expression Level |
parietal lobe |
Human |
|
DAA2255 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
137.3% Increase Gene Expression Level |
hippocampus |
Human |
|
DAA2250 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
165.5% Increase Gene Expression Level |
hippocampus |
Human |
|
DAA2253 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
102.7% Increase Gene Expression Level |
hippocampus |
Human |
|
DAA2252 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
101.8% Increase Gene Expression Level |
hippocampus |
Human |
|
DAA2248 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
30.2% Increase Gene Expression Level |
frontal lobe |
Human |
|
DAA2264 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
CASP1 |
53.3% Increase Gene Expression Level |
parietal lobe |
Human |
|
DAA346 |
CCAAT/enhancer binding protein (C/EBP), alpha |
CEBPA |
28.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
DAA529 |
CCAAT/enhancer binding protein (C/EBP), beta |
CEBPB |
3.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
DAA2221 |
CD14 molecule increases with age |
CD14 |
186.5% Increase Gene Expression Level |
parietal lobe |
Human |
|
DAA2207 |
CD14 molecule increases with age |
CD14 |
395.0% Increase Gene Expression Level |
hippocampus |
Human |
|
DAA2236 |
CD14 molecule increases with age |
CD14 |
134.9% Increase Gene Expression Level |
frontal lobe |
Human |
|
DAA2204 |
CD14 molecule increases with age |
CD14 |
154.3% Increase Gene Expression Level |
temporal lobe |
Human |
|
DAA2273 |
CD163 molecule increases with age |
CD163 |
552.3% Increase Gene Expression Level |
hippocampus |
Human |
|
DAA2272 |
CD163 molecule increases with age |
CD163 |
515.7% Increase Gene Expression Level |
hippocampus |
Human |
|
DAA2288 |
CD163 molecule increases with age |
CD163 |
383.1% Increase Gene Expression Level |
frontal lobe |
Human |
|
DAA2287 |
CD163 molecule increases with age |
CD163 |
283.0% Increase Gene Expression Level |
frontal lobe |
Human |
|
DAA2280 |
CD163 molecule increases with age |
CD163 |
491.5% Increase Gene Expression Level |
parietal lobe |
Human |
|
DAA2279 |
CD163 molecule increases with age |
CD163 |
488.1% Increase Gene Expression Level |
parietal lobe |
Human |
|
DAA469 |
CD207 molecule, langerin |
CD207 |
7.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA2455 |
CD34 antigen isoform b decreases with age |
CD34 |
17.3% Decrease DNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2406 |
CD34 antigen isoform b decreases with age |
CD34 |
16.6% Decrease DNA Methylation |
dermis |
Human |
|
DAA45 |
Cdc2-related kinase, arginine/serine-rich |
CDK12 |
17.0% Increase Gene Expression Level |
brain |
Human |
|